303 related articles for article (PubMed ID: 32845411)
1. An Update on the Pathogenesis of Cutaneous Lupus Erythematosus and Its Role in Clinical Practice.
Patel J; Borucki R; Werth VP
Curr Rheumatol Rep; 2020 Aug; 22(10):69. PubMed ID: 32845411
[TBL] [Abstract][Full Text] [Related]
2. The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosus.
Cho YM; Furie R
Immunotherapy; 2024 Jan; 16(1):15-20. PubMed ID: 37877249
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of cutaneous lupus erythema associated with and without systemic lupus erythema.
Zhang YP; Wu J; Han YF; Shi ZR; Wang L
Autoimmun Rev; 2017 Jul; 16(7):735-742. PubMed ID: 28483542
[TBL] [Abstract][Full Text] [Related]
4. An Update on the Pathogenesis of Skin Damage in Lupus.
Li Q; Wu H; Zhou S; Zhao M; Lu Q
Curr Rheumatol Rep; 2020 May; 22(5):16. PubMed ID: 32399815
[TBL] [Abstract][Full Text] [Related]
5. Emerging immunotherapeutic strategies for cutaneous lupus erythematosus: an overview of recent phase 2 and 3 clinical trials.
Lim D; Kleitsch J; Werth VP
Expert Opin Emerg Drugs; 2023 Dec; 28(4):257-273. PubMed ID: 37860982
[TBL] [Abstract][Full Text] [Related]
6. Immunogenetics of cutaneous lupus erythematosus.
Hersh AO; Arkin LM; Prahalad S
Curr Opin Pediatr; 2016 Aug; 28(4):470-5. PubMed ID: 27386968
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous and systemic connections in lupus.
Maz MP; Michelle Kahlenberg J
Curr Opin Rheumatol; 2020 Nov; 32(6):583-589. PubMed ID: 32826479
[TBL] [Abstract][Full Text] [Related]
8. Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus.
Chen KL; Krain RL; Werth VP
F1000Res; 2019; 8():. PubMed ID: 30984372
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Immune Cells as a Therapy for Cutaneous Lupus Erythematosus.
Soto JA; Melo-González F; Riedel CA; Bueno SM; Kalergis AM
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142624
[TBL] [Abstract][Full Text] [Related]
10. B Cell Signatures Distinguish Cutaneous Lupus Erythematosus Subtypes and the Presence of Systemic Disease Activity.
Abernathy-Close L; Lazar S; Stannard J; Tsoi LC; Eddy S; Rizvi SM; Yee CM; Myers EM; Namas R; Lowe L; Reed TJ; Wen F; Gudjonsson JE; Kahlenberg JM; Berthier CC
Front Immunol; 2021; 12():775353. PubMed ID: 34868043
[TBL] [Abstract][Full Text] [Related]
11. Plasmacytoid Dendritic Cells Are Not Major Producers of Type 1 IFN in Cutaneous Lupus: An In-Depth Immunoprofile of Subacute and Discoid Lupus.
Vazquez T; Patel J; Kodali N; Diaz D; Bashir MM; Chin F; Keyes E; Sharma M; Sprow G; Grinnell M; Dan J; Werth VP
J Invest Dermatol; 2024 Jun; 144(6):1262-1272.e7. PubMed ID: 38086428
[TBL] [Abstract][Full Text] [Related]
12. New insights into the progression from cutaneous lupus to systemic lupus erythematosus.
Zhou W; Wu H; Zhao M; Lu Q
Expert Rev Clin Immunol; 2020 Aug; 16(8):829-837. PubMed ID: 32746644
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions.
Niebel D; de Vos L; Fetter T; Brägelmann C; Wenzel J
Am J Clin Dermatol; 2023 Jul; 24(4):521-540. PubMed ID: 37140884
[TBL] [Abstract][Full Text] [Related]
14. Litifilimab (BIIB059), a promising investigational drug for cutaneous lupus erythematosus.
Cho SK; Vazquez T; Werth VP
Expert Opin Investig Drugs; 2023 May; 32(5):345-353. PubMed ID: 37148249
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients.
Chanprapaph K; Tubtieng I; Pratumchat N; Thadanipon K; Rattanakaemakorn P; Suchonwanit P
Lupus; 2021 Apr; 30(5):785-794. PubMed ID: 33554715
[TBL] [Abstract][Full Text] [Related]
16. Novel biological therapeutic approaches to cutaneous lupus erythematosus.
Tayer-Shifman OE; Rosen CF; Wakani L; Touma Z
Expert Opin Biol Ther; 2018 Oct; 18(10):1041-1047. PubMed ID: 30118337
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune Skin Conditions: Cutaneous Lupus Erythematosus.
Foulke G; Helm LA; Clebak KT; Helm M
FP Essent; 2023 Mar; 526():25-36. PubMed ID: 36913660
[TBL] [Abstract][Full Text] [Related]
18. Role of neutrophils in cutaneous lupus erythematosus.
Yamamoto T
J Dermatol; 2024 Feb; 51(2):180-184. PubMed ID: 38009863
[TBL] [Abstract][Full Text] [Related]
19. The pathogenesis of cutaneous lupus erythematosus: The aberrant distribution and function of different cell types in skin lesions.
Zhou X; Yan J; Lu Q; Zhou H; Fan L
Scand J Immunol; 2021 Jan; 93(1):e12933. PubMed ID: 32654170
[TBL] [Abstract][Full Text] [Related]
20. The role of cytokines in the pathogenesis of cutaneous lupus erythematosus.
Robinson ES; Werth VP
Cytokine; 2015 Jun; 73(2):326-34. PubMed ID: 25767072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
